
Modern Slavery Statement
for Financial Year 2025
This statement, made pursuant to section 54(1) of the Modern Slavery Act 2015, sets out HBSUK’s actions to understand all potential modern slavery risks related to its business and to put in place steps that are aimed at ensuring that there is no slavery or human trafficking in its own business and its supply chains.
As part of the healthcare sector, HBSUK recognises that it has a responsibility to take a robust approach to slavery and human trafficking. HBSUK is absolutely committed to preventing slavery and human trafficking in its corporate activities, and ensuring that those in its supply chains, and contractors, are free from slavery and human trafficking and comply with our values.
Organisational Structure and Supply Chains
HBSUK is a provider of virtual and face to face surgical, triage and outpatient services to insurers, corporate businesses, the NHS, and private patients, on a nationwide basis. HBSUK’s head office is in Nottingham but operates across the UK, in England and Wales.
HBSUK’s supply chain mainly comprises doctors, nurses, and Allied Health Professionals, as individuals or part of groups, providing medical treatments and assessments. Our supply chain also comprises suppliers as expected in the running of business such as facility providers, therapy providers, IT providers, recruitment providers, management consultants and professional services.
Risk Assessment Process
On an annual basis, HBSUK evaluates the business risks, comprising country risks, sector risks, transaction risks and business partnerships, to determine whether particular activities or countries are high risk in relation to slavery or human trafficking. Any risks identified from the above process will be prioritised and dealt with in accordance with the due diligence section below.
High-Risk Activities
HBSUK does not believe it has any particular activities or is involved with any countries which are high risk in relation to slavery or human trafficking.
Responsibility
- Overall: HBSUK Executive Team
- Policies: People Team
- Risk assessment, Due diligence, and Training: Governance Team
Relevant Policies
Due Diligence
HBSUK has committed to undertaking due diligence when considering taking on new suppliers and regularly reviews its existing suppliers. HBSUK’s due diligence and reviews may include:
- Broadly considering suppliers to assess particular product or geographical risks of modern slavery and human trafficking.
- When engaging a new frequent supplier as part of contract negotiations/tender processes, enquire if they are a business that is required to have a Modern Slavery Human Trafficking Statement, and what policies they have in place.
- Evaluating the modern slavery and human trafficking risks of each new supplier.
- Where we identify high risk areas, explore those suppliers in greater detail.
- Taking steps to improve substandard suppliers’ practices, including providing advice to suppliers and requiring them to implement action plans.
- Where a potential frequent supplier is unwilling to provide statements, or complete a questionnaire on the matter, we will consider if we commence that business relationship.
- Invoking sanctions against suppliers that fail to improve their performance in line with an action plan, including the termination of the business relationship.
- Ensuring contractual controls are in place with suppliers in relation to complying with Modern Slavery legislation.
Performance Indicators
In order to assess the effectiveness of our approach to modern slavery HBSUK we continue to evolve our supplier management processes. Our Key Performance Indicators include:
- Staff awareness
- Reviewing existing supply chains; and
- Developing a new suppliers’ evaluation process.
Awareness-Raising Programme
HBSUK will raise awareness of modern slavery issues via our intranet, explaining:
- The basic principles of the Modern Slavery Act 2015.
- How employers can identify and prevent slavery and human trafficking.
- What employees can do to flag up potential slavery or human trafficking issues to the relevant parties within the Company; and
- What external help is available.
This statement has been approved by the Board of Directors on 9 June 2026.
Signed
Keith Misson
CEO
Healthcare Business Solutions (UK) Limited